Published in J Infect Dis on July 11, 2013
4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany. BMC Infect Dis (2014) 1.05
Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom. BMC Infect Dis (2015) 0.94
Available influenza vaccines: immunization strategies, history and new tools for fighting the disease. J Prev Med Hyg (2016) 0.82
Comparative Epidemiology of Influenza B Yamagata- and Victoria-Lineage Viruses in Households. Am J Epidemiol (2015) 0.81
Influenza B virus-specific CD8+ T-lymphocytes strongly cross-react with viruses of the opposing influenza B lineage. J Gen Virol (2015) 0.78
Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden. J Prev Med Hyg (2016) 0.78
Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach. Hum Vaccin Immunother (2016) 0.77
Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial. J Pediatric Infect Dis Soc (2014) 0.77
Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6-35 Months of Age During 2013-2014: Results From A Phase II Randomized Trial. J Pediatric Infect Dis Soc (2015) 0.76
Protection of young children from influenza through universal vaccination. Hum Vaccin Immunother (2015) 0.75
Epidemiological and Virological Characterization of Influenza B Virus Infections. PLoS One (2016) 0.75
The quadrivalent approach to influenza vaccination. J Infect Dis (2013) 0.75
Is the impact of childhood influenza vaccination less than expected: a transmission modelling study. BMC Infect Dis (2017) 0.75
Quadrivalent influenza vaccine in the United States. Hum Vaccin Immunother (2013) 0.75
A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine. BMC Infect Dis (2014) 0.75
Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial. Hum Vaccin Immunother (2015) 0.75
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology (1990) 4.71
Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine (2012) 2.67
Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis (2012) 2.48
Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine (2009) 2.11
The need for quadrivalent vaccine against seasonal influenza. Vaccine (2010) 1.92
Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. Am J Epidemiol (1980) 1.74
Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect (2011) 1.40
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respir Viruses (2011) 1.32
Influenza-associated pediatric deaths--United States, September 2010-August 2011. MMWR Morb Mortal Wkly Rep (2011) 1.22
Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months. Pediatrics (2011) 1.12
Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children. Vaccine (2011) 1.11
Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season. Wkly Epidemiol Rec (2012) 1.07
Influenza Β/Victoria antigen induces strong recall of Β/Yamagata but lower Β/Victoria response in children primed with two doses of Β/Yamagata. Pediatr Infect Dis J (2011) 1.00
Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6-35 Months: A Randomized, Controlled Trial. J Pediatric Infect Dis Soc (2012) 0.97
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93
Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med (2007) 5.87
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials. Lancet Oncol (2015) 4.84
Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg (2003) 4.75
Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes. Diabetes Care (2012) 3.28
Vaccine for prevention of mild and moderate-to-severe influenza in children. N Engl J Med (2013) 3.09
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA (2013) 3.06
Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis (2005) 3.06
Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial. JAMA (2008) 2.88
Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology (2004) 2.74
Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med (2007) 2.56
The changing age and seasonal profile of pertussis in Canada. J Infect Dis (2002) 2.53
Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years. Hum Vaccin (2009) 2.51
Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada. J Pediatr (2003) 2.42
Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol Nutr Food Res (2007) 2.30
Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. J Formos Med Assoc (2009) 2.28
AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. Lancet Infect Dis (2013) 1.95
Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines. J Infect Dis (2012) 1.87
Pandemic influenza in Canadian children: a summary of hospitalized pediatric cases. Vaccine (2010) 1.86
Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics (2009) 1.85
A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med (2010) 1.81
Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology (2010) 1.78
High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother (2003) 1.75
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years. Hum Vaccin (2011) 1.73
Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology (2007) 1.70
Outbreak of atypical pertussis detected by polymerase chain reaction in immunized preschool-aged children. Pediatr Infect Dis J (2009) 1.67
Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine. Am J Trop Med Hyg (2003) 1.65
Burden of seasonal influenza in children with neurodevelopmental conditions. Pediatr Infect Dis J (2014) 1.63
Epidemiology and impacts of children hospitalized with pneumonia from 1997 to 2004 in Taiwan. Pediatr Pulmonol (2009) 1.62
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults. Hum Vaccin (2009) 1.61
Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004. Pediatrics (2006) 1.59
Incidence and case-fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan. J Med Virol (2002) 1.57
A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children. Vaccine (2002) 1.56
Fatal coxsackievirus A16 infection. Pediatr Infect Dis J (2004) 1.55
Is avian influenza A (H7N9) virus staggering its way to humans? J Formos Med Assoc (2013) 1.52
Inadequate pain management during routine childhood immunizations: the nerve of it. Clin Ther (2009) 1.51
Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res (2006) 1.50
Establishment of a young mouse model and identification of an allelic variation of zmpB in complicated pneumonia caused by Streptococcus pneumoniae. Crit Care Med (2008) 1.50
Rates of influenza vaccination in older adults and factors associated with vaccine use: a secondary analysis of the Canadian Study of Health and Aging. BMC Public Health (2004) 1.49
Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations. Vaccine (2011) 1.48
Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years. Hum Vaccin (2011) 1.46
Immunizations for patients with metabolic disorders. Pediatrics (2006) 1.46
Large epidemic of adenovirus type 4 infection among military trainees: epidemiological, clinical, and laboratory studies. Clin Infect Dis (2002) 1.45
Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial. Obstet Gynecol (2016) 1.44
SARS in hospital emergency room. Emerg Infect Dis (2004) 1.44
Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis (2008) 1.43
Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live). Pediatrics (2007) 1.43
Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates. Am J Trop Med Hyg (2003) 1.43
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children. Am J Trop Med Hyg (2008) 1.42
Influenza pandemics: past, present and future. J Formos Med Assoc (2006) 1.41
Vaccination against human papillomavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and beliefs. Vaccine (2007) 1.40
Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. Pediatr Infect Dis J (2007) 1.39
The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada. Pediatr Infect Dis J (2009) 1.38
Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol (2004) 1.34
A phase II, randomized, safety and immunogenicity study of a re-derived, live-attenuated dengue virus vaccine in healthy adults. Am J Trop Med Hyg (2012) 1.31
Trivalent MDCK cell culture-derived influenza vaccine Optaflu (Novartis Vaccines). Expert Rev Vaccines (2009) 1.31
Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet (2012) 1.30
An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model. Vaccine (2005) 1.30
The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007. Vaccine (2009) 1.27
Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans R Soc Trop Med Hyg (2002) 1.27
Community-acquired methicillin-resistant Staphylococcus aureus in children in northern Taiwan. J Microbiol Immunol Infect (2004) 1.26
Carotid artery dissection as a possible severe complication of pertussis in an adult: clinical case report and review. Clin Infect Dis (2002) 1.26
Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested case-control study. Pediatr Infect Dis J (2002) 1.26
Rates and determinants of seasonal influenza vaccination in pregnancy and association with neonatal outcomes. CMAJ (2014) 1.24
Clinical and epidemiological relevance of quantitating hepatitis E virus-specific immunoglobulin M. Clin Diagn Lab Immunol (2002) 1.23
Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial. Pediatrics (2005) 1.22
The yin and yang of paracetamol and paediatric immunisations. Lancet (2009) 1.22
Cotransplantation of umbilical cord-derived mesenchymal stem cells promote hematopoietic engraftment in cord blood transplantation: a pilot study. Transplantation (2013) 1.21
Retracted Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal. J Clin Microbiol (2002) 1.20
Immunization Monitoring Program, Active: a model of active surveillance of vaccine safety. Semin Pediatr Infect Dis (2003) 1.19
Three-year follow-up of protection rates in children given varicella vaccine. Can J Infect Dis (2002) 1.19
Community outbreak of adenovirus, Taiwan, 2011. Emerg Infect Dis (2012) 1.17
Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008. J Microbiol Immunol Infect (2011) 1.16
Clinical features of influenza A and B in children and association with myositis. J Microbiol Immunol Infect (2004) 1.16
A community-derived outbreak of adenovirus type 3 in children in Taiwan between 2004 and 2005. J Med Virol (2008) 1.15
Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002. Pediatrics (2004) 1.15
Progress in development of a live-attenuated, tetravalent dengue virus vaccine by the United States Army Medical Research and Materiel Command. Am J Trop Med Hyg (2003) 1.15
Differences in replication capacity between enterovirus 71 isolates obtained from patients with encephalitis and those obtained from patients with herpangina in Taiwan. J Med Virol (2007) 1.14
Comparison of children hospitalized with seasonal versus pandemic influenza A, 2004-2009. Pediatrics (2012) 1.13
Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan. Vaccine (2009) 1.12
Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months. Pediatrics (2011) 1.12
Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis. Emerg Infect Dis (2004) 1.12
Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults. Hum Vaccin (2011) 1.12
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013. Pediatr Infect Dis J (2015) 1.12
Effect on cellular and humoral immune responses of the AS03 adjuvant system in an A/H1N1/2009 influenza virus vaccine administered to adults during two randomized controlled trials. Clin Vaccine Immunol (2011) 1.12
Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city. J Microbiol Immunol Infect (2011) 1.12
Adenovirus serotype 3 and 7 infection with acute respiratory failure in children in Taiwan, 2010-2011. PLoS One (2013) 1.11
Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate. J Infect Dis (2011) 1.11
Influenza in Taiwan: seasonality and vaccine strain match. J Microbiol Immunol Infect (2005) 1.10
Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines. PLoS One (2011) 1.10
Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation (2011) 1.10
A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents. Pediatr Infect Dis J (2009) 1.09
Rapid detection of adenovirus in throat swab specimens by PCR during respiratory disease outbreaks among military recruits. J Clin Microbiol (2003) 1.09